Information:
Fel:
ID
12208
Beskrivning
Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02312063
Länk
https://clinicaltrials.gov/show/NCT02312063
Nyckelord
Versioner (1)
- 2015-10-18 2015-10-18 -
Uppladdad den
18 oktober 2015
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Diabetes Mellitus, Type 2 NCT02312063
Eligibility Diabetes Mellitus, Type 2 NCT02312063
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT02312063
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
metformin; japanese
Item
japanese t2dm patients, who are oad nave or receive 4-week wash out of one oad (glinides, alpha-gi, metformin) before randomization.
boolean
C0025598 (UMLS CUI [1])
C1556094 (UMLS CUI [2])
C1556094 (UMLS CUI [2])
hba1c
Item
hba1c:6.0-8.0 %
boolean
C0366781 (UMLS CUI [1])
bmi
Item
bmi:18-30 kg/m2
boolean
C1305855 (UMLS CUI [1])
age
Item
age:20-75 years old
boolean
C0001779 (UMLS CUI [1])
Creatinine clearance
Item
crcl: > 60ml/min
boolean
C0812399 (UMLS CUI [1])
glimepiride
Item
patients on dpp-4 inhibitors or glimepiride
boolean
C0061323 (UMLS CUI [1])
pioglitazone
Item
patients treated with pioglitazone
boolean
C0071097 (UMLS CUI [1])
Renal Insufficiency
Item
patients with moderate/severe renal impairments
boolean
C1565489 (UMLS CUI [1])
Insulin Receptor Agonists
Item
patients with insulin or glp-1 receptor agonists
boolean
C1373092 (UMLS CUI [1])